Incyte News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.06.17	New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017 (PR Newswire)
14.06.17	Lilly to Present New Data on Olumiant® (baricitinib) in Rheumatoid Arthritis and Taltz® (ixekizumab) in Psoriatic Arthritis at the Annual European Congress of Rheumatology (EULAR 2017) (PR Newswire)
11.05.17	Technical Reports on Biotech Stocks -- Celsion, Incyte, ImmunoGen, and Catabasis Pharma (PR Newswire)
04.05.17	EARNINGS SUMMARY: Details of Incyte Corporation Q1 Earnings Report (RTTNews)
04.05.17	Incyte Posts Q1 Loss On Higher R&D Expenses; Jakafi Revenues Up 37% (RTTNews)
29.04.17	Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc. (PR Newswire)
20.04.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY) (PR Newswire)
19.04.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY (PR Newswire)
18.04.17	Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... (RTTNews)
17.04.17	MÄRKTE USA/Berichtssaison verdrängt geopolitische -2- (Dow Jones)
17.04.17	MÄRKTE USA/Berichtssaison verdrängt geopolitische Sorgen an der Wall Street (Dow Jones)
17.04.17	Incyte Continues To Post Steep Loss After Initial Sell-Off (RTTNews)
17.04.17	FDA Says No To INCY, ZTS Snaps Up NVET, MDXG On The Move (RTTNews)
14.04.17	Eli Lilly And Incyte Say FDA Issues CRL For Baricitinib (RTTNews)
14.04.17	U.S. FDA Issues Complete Response Letter for Baricitinib (PR Newswire)
13.04.17	Company Spotlight: Incyte (RTTNews)
03.04.17	Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise (RTTNews)
31.03.17	Incyte, Merck Give Further Details On Epacadostat - KEYTRUDA Clinical Program (RTTNews)
24.03.17	Biotech Stocks Facing FDA Decision In April (RTTNews)
03.03.17	How These Biotech Stocks are Faring? -- Geron, Incyte, Illumina, and Bellerophon Therapeutics (PR Newswire)
23.02.17	Incyte, CBOE Holdings, Regency Centers Set to Join S&P 500; Others to Join S&P MidCap 400 (PR Newswire)
15.02.17	Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show baricitinib-treated patients demonstrated sustained improvement in rheumatoid arthritis compared to... (PR Newswire)
14.02.17	Incyte Corporation Bottom Line Falls 84% In Q4 (RTTNews)
13.02.17	European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis (PR Newswire)
13.02.17	European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis (PR Newswire)
30.01.17	Incyte And Calithera Collaborate To Develop And Commercialize CB-1158 (RTTNews)
17.01.17	FDA Delays Decision On Lilly's Rheumatoid Arthritis Drug Candidate (RTTNews)
13.01.17	U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment (PR Newswire)
09.01.17	Incyte & Merck Expand Clinical Trial On Combination Of Epacadostat With KEYTRUDA (RTTNews)
29.12.16	Research Reports Initiation on Biotech Stocks -- Incyte, Anavex Life Sciences, Portola Pharma, and Spectrum Pharma (PR Newswire)
29.12.16	Biotech Stocks Facing FDA Decision In January (RTTNews)
16.12.16	CHMP Recommends Approval Of Lilly's Baricitinib For Rheumatoid Arthritis (RTTNews)
16.12.16	CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis (RA) (PR Newswire)
14.11.16	Lilly Says New Analyses Of Phase 3 Trials Show Improvements In RA Symptom (RTTNews)
01.11.16	EARNINGS SUMMARY: Details of Incyte Corporation Q3 Earnings Report (RTTNews)
01.11.16	Incyte Corp. Updates 2016 Guidance - Quick Facts (RTTNews)
27.09.16	Incyte : NCCN Guidelines Recommend Jakafi For Treatment Of Myelofibrosis (RTTNews)
09.08.16	Incyte Corporation Q2 Earnings Climb 271% (RTTNews)
23.06.16	Incyte: Ruxolitinib Receives Breakthrough Therapy Designation - Quick Facts (RTTNews)
23.06.16	NYMX Grabs Headlines, MRNS Awaits Data In 2H, PSTI Takes Small Step In DMD Race (RTTNews)
09.06.16	Lilly : Baricitinib Reduces Joint Damage Progression In Rheumatoid Arthritis (RTTNews)
09.05.16	Incyte To Acquire ARIAD's European Operations, In-license Iclusig In Europe (RTTNews)
09.05.16	EARNINGS SUMMARY: Details of Incyte Corporation Q1 Earnings Report (RTTNews)
07.04.16	BIND In A Fix, APRI To File NDA In Q3, TSRO Abuzz (RTTNews)
06.04.16	Incyte Acquires Rights To Ruxolitinib From Eli Lilly - Quick Facts (RTTNews)
24.03.16	Aduro : First Patient Dosed In CRS-207-Epacadostat Trial To Treat Ovarian Cancer (RTTNews)
12.02.16	AEGR Lays Off 25% Staff, INCY Discontinues Ruxolitinib Trials, ZBH Gets FDA Nod (RTTNews)
11.02.16	Incyte Expects 2016 Jakafi Product Revenues Of $800-$815 Mln - Quick Facts (RTTNews)
11.02.16	EARNINGS SUMMARY: Details of Incyte Corporation Q4 Earnings Report (RTTNews)
11.02.16	Incyte To Discontinue JANUS Studies Of Ruxolitinib Plus Capecitabine (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

04.12.24		Gewinne in New York: S&P 500 legt mittags zu
19.11.24		Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind
19.11.24		Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen
19.11.24		Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen
19.11.24		Verluste in New York: S&P 500 startet im Minus
29.10.24		Börse New York in Grün: S&P 500 beendet die Sitzung im Plus
29.10.24		Börse New York: S&P 500 fester
29.10.24		Optimismus in New York: So bewegt sich der S&P 500 am Mittag

04.12.24

Gewinne in New York: S&P 500 legt mittags zu

19.11.24

Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind

19.11.24

Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen

19.11.24

Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen

19.11.24

Verluste in New York: S&P 500 startet im Minus

29.10.24

Börse New York in Grün: S&P 500 beendet die Sitzung im Plus